BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Boer YS, Kosinski AS, Urban TJ, Zhao Z, Long N, Chalasani N, Kleiner DE, Hoofnagle JH; Drug-Induced Liver Injury Network. Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol 2017;15:103-112.e2. [PMID: 27311619 DOI: 10.1016/j.cgh.2016.05.043] [Cited by in Crossref: 85] [Cited by in F6Publishing: 66] [Article Influence: 14.2] [Reference Citation Analysis]
Number Citing Articles
1 Tillmann HL, Rockey DC. Signatures in drug-induced liver injury: . Current Opinion in Gastroenterology 2020;36:199-205. [DOI: 10.1097/mog.0000000000000636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Harmon EG, McConnie R, Kesavan A. Minocycline-Induced Autoimmune Hepatitis: A Rare But Important Cause of Drug-Induced Autoimmune Hepatitis. Pediatr Gastroenterol Hepatol Nutr 2018;21:347-50. [PMID: 30345250 DOI: 10.5223/pghn.2018.21.4.347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 de Boer YS, Liberal R, Vergani D, Mieli-Vergani G. Real-world management of juvenile autoimmune liver disease. United European Gastroenterol J 2018;6:1032-8. [PMID: 30228891 DOI: 10.1177/2050640618768922] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Fontana RJ, Cirulli ET, Gu J, Kleiner D, Ostrov D, Phillips E, Schutte R, Barnhart H, Chalasani N, Watkins PB, Hoofnagle JH. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. J Hepatol 2018;69:1317-25. [PMID: 30138689 DOI: 10.1016/j.jhep.2018.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
5 Kleiner DE. Histopathological challenges in suspected drug-induced liver injury. Liver Int 2018;38:198-209. [PMID: 28865179 DOI: 10.1111/liv.13584] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
6 Li X, Xu H, Gao P. Increased red cell distribution width predicts severity of drug-induced liver injury: a retrospective study. Sci Rep 2021;11:773. [PMID: 33436893 DOI: 10.1038/s41598-020-80116-4] [Reference Citation Analysis]
7 Bhardwaj M, Bhardwaj NJ, Cueto K, Killeen TC. Hydralazine-induced liver injury: a review and discussion. BMJ Case Rep 2021;14:e243278. [PMID: 34404652 DOI: 10.1136/bcr-2021-243278] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Schneider JS, Montani M, Stickel F. Drug-Induced Autoimmune Hepatitis following Treatment with Zoledronic Acid. Case Rep Gastroenterol 2017;11:440-5. [PMID: 29033761 DOI: 10.1159/000479314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Buechter M, Manka P, Heinemann FM, Lindemann M, Baba HA, Schlattjan M, Canbay A, Gerken G, Kahraman A. Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients. World J Gastroenterol 2018; 24(13): 1410-1418 [PMID: 29632422 DOI: 10.3748/wjg.v24.i13.1410] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
10 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 155] [Article Influence: 66.0] [Reference Citation Analysis]
11 Stephens C, Andrade RJ. Genetic Predisposition to Drug-Induced Liver Injury. Clin Liver Dis 2020;24:11-23. [PMID: 31753244 DOI: 10.1016/j.cld.2019.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
12 Aizawa Y, Hokari A. Autoimmune hepatitis: current challenges and future prospects. Clin Exp Gastroenterol. 2017;10:9-18. [PMID: 28176894 DOI: 10.2147/ceg.s101440] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
13 Kleiner DE. Drug-induced Liver Injury: The Hepatic Pathologist's Approach. Gastroenterol Clin North Am 2017;46:273-96. [PMID: 28506365 DOI: 10.1016/j.gtc.2017.01.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
14 Bril F, Al Diffalha S, Dean M, Fettig DM. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty? J Hepatol 2021;75:222-4. [PMID: 33862041 DOI: 10.1016/j.jhep.2021.04.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
15 Valgeirsson KB, Hreinsson JP, Björnsson ES. Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs. Liver Int 2019;39:2341-9. [PMID: 31436903 DOI: 10.1111/liv.14224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Rong J, Xie Z, Chen E, Ma S, Zhang S, Zhao Y, Xu X, Li L. Fructus Psoraleae-Induced Severe Liver Injury and Treatment With Two Artificial Liver Support Systems: A Case Series Study. Ther Apher Dial 2020;24:324-32. [PMID: 31577858 DOI: 10.1111/1744-9987.13438] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Lammert C. Genetic and Environmental Risk Factors for Autoimmune Hepatitis. Clin Liver Dis (Hoboken) 2019;14:29-32. [PMID: 31391934 DOI: 10.1002/cld.798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Reference Citation Analysis]
19 Shao Q, Mao X, Zhou Z, Huai C, Li Z. Research Progress of Pharmacogenomics in Drug-Induced Liver Injury. Front Pharmacol 2021;12:735260. [PMID: 34552491 DOI: 10.3389/fphar.2021.735260] [Reference Citation Analysis]
20 Lammert C, Zhu C, Lian Y, Raman I, Eckert G, Li QZ, Chalasani N. Exploratory Study of Autoantibody Profiling in Drug-Induced Liver Injury with an Autoimmune Phenotype. Hepatol Commun 2020;4:1651-63. [PMID: 33163835 DOI: 10.1002/hep4.1582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Das A, Guarda LA, Allen LG. Liver Injury Associated With Quetiapine: An Illustrative Case Report. J Clin Psychopharmacol 2017;37:623-5. [PMID: 28786826 DOI: 10.1097/JCP.0000000000000749] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Kleiner DE. The histopathological evaluation of drug-induced liver injury. Histopathology. 2017;70:81-93. [PMID: 27960237 DOI: 10.1111/his.13082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
23 Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy. Liver Int. 2018;38:6-14. [PMID: 28771932 DOI: 10.1111/liv.13535] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
24 Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int J Mol Sci 2021;22:2954. [PMID: 33799477 DOI: 10.3390/ijms22062954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Björnsson HK, Gudbjornsson B, Björnsson ES. Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment. J Hepatol 2021:S0168-8278(21)02022-5. [PMID: 34487751 DOI: 10.1016/j.jhep.2021.08.024] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sernoskie SC, Jee A, Uetrecht JP. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions. Pharmacol Rev 2021;73:861-96. [PMID: 34016669 DOI: 10.1124/pharmrev.120.000090] [Reference Citation Analysis]
27 Björnsson ES, Andrade RJ. Long-term sequelae of Drug-induced liver injury. J Hepatol 2021:S0168-8278(21)02118-8. [PMID: 34688732 DOI: 10.1016/j.jhep.2021.10.011] [Reference Citation Analysis]
28 Rahim MN, Liberal R, Miquel R, Heaton ND, Heneghan MA. Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation? Liver Transpl 2019;25:946-59. [PMID: 30900368 DOI: 10.1002/lt.25451] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
29 Shahbaz O, Mahajan S, Lewis JH. Highlights of Drug - and Herb- induced liver injury in the Literature from 2016: How Best to Translate New Information into Clinical Practice? Expert Opin Drug Metab Toxicol. 2017;13:935-951. [PMID: 28772086 DOI: 10.1080/17425255.2017.1362391] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
30 Kleiner DE. Recent Advances in the Histopathology of Drug-Induced Liver Injury. Surg Pathol Clin. 2018;11:297-311. [PMID: 29751876 DOI: 10.1016/j.path.2018.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
31 Dong Y, Potthoff A, Klinger C, Barreiros AP, Pietrawski D, Dietrich CF. Ultrasound findings in autoimmune hepatitis. World J Gastroenterol 2018; 24(15): 1583-1590 [PMID: 29686465 DOI: 10.3748/wjg.v24.i15.1583] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
32 Andrade RJ, Robles‐díaz M. Diagnostic and prognostic assessment of suspected drug‐induced liver injury in clinical practice. Liver Int 2019;40:6-17. [DOI: 10.1111/liv.14271] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
33 Ogese MO, Ahmed S, Alferivic A, Betts CJ, Dickinson A, Faulkner L, French N, Gibson A, Hirschfield GM, Kammüller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell AW, Spraggs CF, Whritenour J, Naisbitt DJ. New Approaches to Investigate Drug-Induced Hypersensitivity. Chem Res Toxicol 2017;30:239-59. [DOI: 10.1021/acs.chemrestox.6b00333] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
34 Febres-Aldana CA, Alghamdi S, Krishnamurthy K, Poppiti RJ. Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases. J Clin Transl Hepatol 2019;7:21-6. [PMID: 30944815 DOI: 10.14218/JCTH.2018.00053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Kawabata H, Kawakatsu Y, Inoue N, Okazaki Y, Sone D, Yamaguchi K, Ueda Y, Hitomi M, Miyata M, Motoi S, Enoki Y, Minamikawa T. IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology. Intern Med 2020;59:1401-5. [PMID: 32475907 DOI: 10.2169/internalmedicine.4092-19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Woolbright BL, Jaeschke H. Mechanisms of Inflammatory Liver Injury and Drug-Induced Hepatotoxicity. Curr Pharmacol Rep 2018;4:346-57. [PMID: 30560047 DOI: 10.1007/s40495-018-0147-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
37 Thomas AM, Lewis JH. Nonacetaminophen Drug-Induced Acute Liver Failure. Clinics in Liver Disease 2018;22:301-24. [DOI: 10.1016/j.cld.2018.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Kerkar N, Chan A. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome. Clinics in Liver Disease 2018;22:689-702. [DOI: 10.1016/j.cld.2018.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
39 Lodato F, Larocca A, D'Errico A, Cennamo V. An unusual case of acute cholestatic hepatitis after m-RNABNT162b2 (Comirnaty) SARS-CoV-2 vaccine: Coincidence, autoimmunity or drug-related liver injury. J Hepatol 2021:S0168-8278(21)01904-8. [PMID: 34256064 DOI: 10.1016/j.jhep.2021.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Nociti V, Biolato M, De Fino C, Bianco A, Losavio FA, Lucchini M, Marrone G, Grieco A, Mirabella M. Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients. Brain Behav 2018;8:e00968. [PMID: 29729087 DOI: 10.1002/brb3.968] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
41 Pillaye JN, Marakalala MJ, Khumalo N, Spearman W, Ndlovu H. Mechanistic insights into antiretroviral drug-induced liver injury. Pharmacol Res Perspect 2020;8:e00598. [PMID: 32643320 DOI: 10.1002/prp2.598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Hassan A, Fontana RJ. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019;39:31-41. [PMID: 30003672 DOI: 10.1111/liv.13931] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
43 Wang Q, Huang A, Wang JB, Zou Z. Chronic Drug-Induced Liver Injury: Updates and Future Challenges. Front Pharmacol 2021;12:627133. [PMID: 33762948 DOI: 10.3389/fphar.2021.627133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Miller ED, Abu-sbeih H, Chalasani NP. Drug-Induced Liver Injury in Older Adults. In: Pitchumoni CS, Dharmarajan T, editors. Geriatric Gastroenterology. Cham: Springer International Publishing; 2019. pp. 1-16. [DOI: 10.1007/978-3-319-90761-1_53-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Björnsson ES. Drug-induced liver injury due to antibiotics. Scand J Gastroenterol 2017;52:617-23. [PMID: 28276834 DOI: 10.1080/00365521.2017.1291719] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
46 Liwinski T, Schramm C. Autoimmune hepatitis — update on clinical management in 2017. Clinics and Research in Hepatology and Gastroenterology 2017;41:617-25. [DOI: 10.1016/j.clinre.2017.07.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
47 Reike-Kunze M, Zenouzi R, Hartel J, Krech T, Weidemann S, Sterneck M, Weiler-Normann C, Lohse AW, Schramm C, Sebode M. Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome. Liver Int 2021. [PMID: 34152686 DOI: 10.1111/liv.14985] [Reference Citation Analysis]
48 Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, Cubero FJ. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel) 2021;10:390. [PMID: 33807700 DOI: 10.3390/antiox10030390] [Reference Citation Analysis]
49 Gasmi B, Kleiner DE. Liver Histology: Diagnostic and Prognostic Features. Clin Liver Dis 2020;24:61-74. [PMID: 31753251 DOI: 10.1016/j.cld.2019.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
50 Urban TJ, Nicoletti P, Chalasani N, Serrano J, Stolz A, Daly AK, Aithal GP, Dillon J, Navarro V, Odin J, Barnhart H, Ostrov D, Long N, Cirulli ET, Watkins PB, Fontana RJ; Drug-Induced Liver Injury Network (DILIN)., Pharmacogenetics of Drug-Induced Liver Injury group (DILIGEN)., International Serious Adverse Events Consortium (iSAEC). Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor. J Hepatol 2017;67:137-44. [PMID: 28323125 DOI: 10.1016/j.jhep.2017.03.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 13.6] [Reference Citation Analysis]
51 Watkins PB. Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implications. Adv Pharmacol 2019;85:165-93. [PMID: 31307586 DOI: 10.1016/bs.apha.2019.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Dara L, Kaplowitz N. Drug‐Induced Liver Injury. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 701-13. [DOI: 10.1002/9781119436812.ch54] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
53 Björnsson HK, Björnsson ES. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management. Eur J Intern Med 2021:S0953-6205(21)00375-7. [PMID: 34772600 DOI: 10.1016/j.ejim.2021.10.035] [Reference Citation Analysis]
54 Gerussi A, Natalini A, Antonangeli F, Mancuso C, Agostinetto E, Barisani D, Di Rosa F, Andrade R, Invernizzi P. Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models. Int J Mol Sci 2021;22:4557. [PMID: 33925355 DOI: 10.3390/ijms22094557] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Bertoli R, Mazzucchelli L, Nofziger C, Paulmichl M, Vergani D. Atovaquone/proguanil-induced autoimmune-like hepatitis. Hepatol Commun 2017;1:293-8. [PMID: 29404460 DOI: 10.1002/hep4.1039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
56 Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671-722. [PMID: 31863477 DOI: 10.1002/hep.31065] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 52.0] [Reference Citation Analysis]
57 Komori A. Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol 2021;27:58-69. [PMID: 33291862 DOI: 10.3350/cmh.2020.0189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Mahmud N, Forde KA. Autoimmunity in Indeterminate Etiologies of Acute Liver Failure: Is This Autoimmune Liver Disease or an Autoimmune Phenotype to Drug Toxicity? Liver Transpl 2020;26:743-5. [PMID: 32279421 DOI: 10.1002/lt.25776] [Reference Citation Analysis]
59 Deng J, Wei W, Chen Z, Lin B, Zhao W, Luo Y, Zhang X. Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review. Micromachines (Basel) 2019;10:E676. [PMID: 31591365 DOI: 10.3390/mi10100676] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 14.7] [Reference Citation Analysis]
60 Lammert C, Chalasani SN, Atkinson EJ, McCauley BM, Lazaridis KN. Environmental risk factors are associated with autoimmune hepatitis. Liver Int 2021;41:2396-403. [PMID: 33978301 DOI: 10.1111/liv.14944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Watanabe M, Shibuya A, Yokomori H, Koizumi W. The Diagnosis of Drug-induced Liver Injury: Current Diagnostic Ability and Future Challenges of the Digestive Disease Week-Japan 2004 Scale 15 Years after Its Proposal. Intern Med 2021;60:2557-68. [PMID: 33716281 DOI: 10.2169/internalmedicine.6370-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Matsumoto K, Kikuchi K, Kajiyama Y, Takano Y, Mabuchi M, Doi S, Sato K, Miyakawa H, Yasuda I. Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection. Intern Med 2018;57:2669-73. [PMID: 29709942 DOI: 10.2169/internalmedicine.0613-17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 Meunier L, Ursic-Bedoya J, Pageaux GP, Larrey D. Pantoprazole-induced autoimmune chronic hepatitis. Liver Int 2018;38:995-9. [PMID: 29532602 DOI: 10.1111/liv.13737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
64 Lammert C, Chalasani SN, Green K, Atkinson E, McCauley B, Lazaridis KN. Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption. Dig Dis Sci 2021. [PMID: 33939140 DOI: 10.1007/s10620-021-06989-1] [Reference Citation Analysis]
65 Lin L, Chen Y, Li Q, Xu G, Ding K, Ren L, Shi W, Wang Y, Li Z, Dai W, Wei Z, Yang Y, Bai Z, Xiao X. Isoxanthohumol, a component of Sophora flavescens, promotes the activation of the NLRP3 inflammasome and induces idiosyncratic hepatotoxicity. J Ethnopharmacol 2022;285:114796. [PMID: 34740771 DOI: 10.1016/j.jep.2021.114796] [Reference Citation Analysis]
66 Björnsson ES, Bergmann O, Jonasson JG, Grondal G, Gudbjornsson B, Olafsson S. Drug-Induced Autoimmune Hepatitis: Response to Corticosteroids and Lack of Relapse After Cessation of Steroids. Clinical Gastroenterology and Hepatology 2017;15:1635-6. [DOI: 10.1016/j.cgh.2017.05.027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
67 Kullak-Ublick GA, Andrade RJ, Merz M, End P, Benesic A, Gerbes AL, Aithal GP. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut 2017;66:1154-64. [PMID: 28341748 DOI: 10.1136/gutjnl-2016-313369] [Cited by in Crossref: 196] [Cited by in F6Publishing: 176] [Article Influence: 39.2] [Reference Citation Analysis]
68 Real M, Barnhill MS, Higley C, Rosenberg J, Lewis JH. Drug-Induced Liver Injury: Highlights of the Recent Literature. Drug Saf 2019;42:365-87. [PMID: 30343418 DOI: 10.1007/s40264-018-0743-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 18.0] [Reference Citation Analysis]
69 Weber S, Benesic A, Rotter I, Gerbes AL. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis. Liver Int 2019;39:1906-17. [PMID: 31319011 DOI: 10.1111/liv.14195] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
70 Martínez-casas OY, Díaz-ramírez GS, Marín-zuluaga JI, Muñoz-maya O, Santos O, Donado-gómez JH, Restrepo-gutiérrez JC. Differential characteristics in drug-induced autoimmune hepatitis: Drug-induced autoimmune hepatitis. JGH Open 2018;2:97-104. [DOI: 10.1002/jgh3.12054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
71 Stephens C, Robles-diaz M, Medina-caliz I, Garcia-cortes M, Ortega-alonso A, Sanabria-cabrera J, Gonzalez-jimenez A, Alvarez-alvarez I, Slim M, Jimenez-perez M, Gonzalez-grande R, Fernández MC, Casado M, Soriano G, Román E, Hallal H, Romero-gomez M, Castiella A, Conde I, Prieto M, Moreno-planas JM, Giraldez A, Moreno-sanfiel JM, Kaplowitz N, Lucena MI, Andrade RJ, Andrade R, Lucena M, Stephens C, Cortés MG, Robles-díaz M, Ortega-alonso A, Pinazo J, Muñoz BG, Alcántara R, Hernández A, Escaño MG, del Campo E, Medina-cáliz I, Sanabria-cabrera J, González-jiménez A, Sanjuán-jiménez R, Cueto A, Álvarez-álvarez I, Bonilla E, Di Zeo D, Niu H, Villanueva M, Papineau A, Pérez MJ, Grande RG, Ortega SL, Santaella I, Ocaña A, Palomino P, Fernández M, Peláez G, Porcel A, Casado M, Sánchez MG, Romero-gómez M, Millán-domínguez R, Fombuena B, Gallego R, Ampuero J, Campo JD, Calle-sanz R, Rojas L, Rojas A, Gómez AG, Vilar E, Soriano G, Guarner C, Román E, Manuitt MQ, Arbos RA, Delgado JS, Gómez MV, Hallal H, Oltra EG, Arcos JT, Martínez AP, Cobarro CS, Caparrós JE, Castiella A, Zapata E, Arenas J, García AG, Esandi F, Blanco S, Odriozola PM, Crespo J, Iruzubieta P, Cabezas J, Gallego AG, Rodríguez Seguel EDP, Cuaresma M, Gallego JG, Jorquera F, Campos SS, Otazua P, de Juan Gómez A, Salmerón J, Gila A, Quiles R, González J, Lorenzo S, Prieto M, Amiel IC, Berenguer M, García-eliz M, Primo J, Molés J, Garayoa A, Carrascosa M, Domínguez EG, Cuevas L, Farré M, Montané E, Barriocanal A, Arellano A, Sanz Y, Morillas R, Sala M, Ridaura HM, Bruguera M, Gines P, Lens S, García J, Mariño Z, Guerra MH, Sanfiel JM, Fernández del Campo CB, Tejedor M, Ferrer RG, Fernández C, Gil MF, Montero J, Mata MDL, Olmo JF, Bonilla EF, Moreno J, Martínez-rodenas P, Garrido M, Oliva C, Rendón P, Samaniego JG, Madejón A, Calleja J, Porras JM, Cabriada J, Pérez-moreno J, Lara C. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. Journal of Hepatology 2021;75:86-97. [DOI: 10.1016/j.jhep.2021.01.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
72 Tillmann HL, Barnhart HX, Serrano J, Rockey DC. Novel Approaches to Causality Adjudication in Drug-Induced Liver Disease. Curr Hepatol Rep 2018;17:276-82. [PMID: 30766772 DOI: 10.1007/s11901-018-0416-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]